CIP
CLX icon

Champlain Investment Partners’s Clorox CLX Stock Holding History

Champlain Investment Partners’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-521,745
Closed -$64.3M – 133
2025
Q3 		$64.3M Sell
521,745
-243,059
-32% -$30.2M 0.49% 89
2025
Q2 		$91.8M Sell
764,804
-93,340
-11% -$12.5M 0.64% 70
2025
Q1 		$126M Sell
858,144
-70,090
-8% -$10.7M 0.92% 39
2024
Q4 		$151M Sell
928,234
-78,020
-8% -$12.8M 0.95% 35
2024
Q3 		$164M Sell
1,006,254
-555,385
-36% -$82.3M 0.99% 38
2024
Q2 		$213M Sell
1,561,639
-6,200
-0.4% -$861K 1.31% 21
2024
Q1 		$240M Sell
1,567,839
-33,075
-2% -$4.94M 1.37% 18
2023
Q4 		$228M Buy
1,600,914
+449,310
+39% +$59.9M 1.35% 20
2023
Q3 		$151M Sell
1,151,604
-6,110
-0.5% -$929K 0.98% 37
2023
Q2 		$184M Buy
1,157,714
+59,935
+5% +$9.67M 1.13% 28
2023
Q1 		$174M Sell
1,097,779
-15,605
-1% -$2.34M 1.09% 29
2022
Q4 		$156M Sell
1,113,384
-3,386
-0.3% -$481K 1% 34
2022
Q3 		$143M Sell
1,116,770
-22,365
-2% -$3.23M 0.98% 35
2022
Q2 		$161M Sell
1,139,135
-304,090
-21% -$43.4M 1.04% 33
2022
Q1 		$201M Buy
1,443,225
+12,554
+0.9% +$1.92M 1.04% 35
2021
Q4 		$249M Sell
1,430,671
-20,660
-1% -$3.44M 1.13% 23
2021
Q3 		$240M Buy
1,451,331
+55,806
+4% +$9.61M 1.15% 22
2021
Q2 		$251M Buy
1,395,525
+356,260
+34% +$65M 1.19% 25
2021
Q1 		$200M Buy
+1,039,265
New +$200M 1.04% 34
2014
Q4 		– Sell
-141,600
Closed -$13.6M – 136
2014
Q3 		$13.6M Sell
141,600
-230,985
-62% -$20.9M 0.24% 118
2014
Q2 		$34.1M Buy
372,585
+58,805
+19% +$5.27M 0.56% 81
2014
Q1 		$27.6M Buy
313,780
+112,350
+56% +$9.86M 0.48% 98
2013
Q4 		$18.7M Sell
201,430
-90,590
-31% -$8.16M 0.33% 111
2013
Q3 		$23.9M Buy
292,020
+17,150
+6% +$1.45M 0.45% 91
2013
Q2 		$22.9M Buy
+274,870
New +$23.6M 0.46% 90

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Champlain Investment Partners's CLX Position: Q4 2025 in Review

Champlain Investment Partners sold out of Clorox (CLX) in Q4 2025, closing a stake of 521,745 shares — an estimated $64.3M sold.

Champlain Investment Partners first reported a position in CLX in Q2 2013 and held it in 25 quarters. The position peaked at $251M in Q2 2021. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Champlain Investment Partners reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Champlain Investment Partners sold 521,745 Clorox shares in Q4 2025, an estimated $64.3M.
  • Champlain Investment Partners first reported a position in Clorox in Q2 2013 and held it in 25 quarters.
  • Champlain Investment Partners's Clorox position peaked at $251M in Q2 2021.
  • 1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Champlain Investment Partners's 13F filing for Q4 2025, filed 13 Feb 2026.